Life Sciences Due Diligence Process Overview

This document is a guide that outlines the life sciences due diligence process, emphasizing the importance of identifying legal risks prior to transactions in the highly regulated life sciences sector. It describes how Epstein Becker Green's attorneys assist private equity firms and investors in evaluating potential risks associated with their transactions. The guide details the creation of a due diligence plan tailored to the investor's risk tolerance and objectives. It explains the process of assembling cross-functional teams to conduct thorough regulatory reviews, including the examination of regulatory compliance, marketing approvals, and potential fraud issues. The document also highlights the communication of findings to clients, which aids in shaping their investment strategies and post-closing integration plans. Overall, it presents a structured approach to navigating the complexities of life sciences transactions.